Archive - June 2021
Moderna says its COVID-19 vaccine appears effective against Delta and other variants
EU identifies first five ‘promising’ COVID-19 drugs as part of therapeutics strategy
Pardes Biosciences, backed by Gilead and Foresite, goes public to advance lead COVID-19 antiviral drug
Gilead seeks US approval for long-acting HIV drug lenacapavir
MHRA approves Paion’s ‘ultra-short-acting’ anaesthetic Byfavo
EC green light for Opdivo plus Yervoy in metastatic colorectal cancer
bluebird bio’s sickle cell gene therapy granted MHRA ‘innovation passport’
Did Sydney’s Lockdown Come Too Late? Here’s Why It’s Not That Simple